Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Behr

Showing results (361-370 of 382) with videos related to

Pageof 39
Sort By:
JCI Insight|October 11, 2019
KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization patternAlexander Teumer, Teresa Trenkwalder, Thorsten Kessler, et al.
European Heart Journal|August 2, 2023
Clinical presentation of calmodulin mutations: the International Calmodulinopathy RegistryLia Crotti, Carla Spazzolini, Mette Nyegaard, et al.
Circulation|December 7, 2021
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular TachycardiaPuck J Peltenburg, Dania Kallas, Johan M Bos, et al.
Circulation|July 25, 2024
Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS StudyRachel Lampert, Sharlene Day, Barbara Ainsworth, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
European Heart Journal|July 31, 2018
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroupsAlban-Elouen Baruteau, Florence Kyndt, Elijah R Behr, et al.
Nature Genetics|July 23, 2013
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathConnie R Bezzina, Julien Barc, Yuka Mizusawa, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Cardiovascular Research|December 5, 2021
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis, Colin Baigent, Stephan Windecker, et al.
Pageof 39

Showing results (361-370 of 382) with videos related to

Sort By:
Pageof 39
JCI Insight|October 11, 2019
KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization patternAlexander Teumer, Teresa Trenkwalder, Thorsten Kessler, et al.
European Heart Journal|August 2, 2023
Clinical presentation of calmodulin mutations: the International Calmodulinopathy RegistryLia Crotti, Carla Spazzolini, Mette Nyegaard, et al.
Circulation|December 7, 2021
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular TachycardiaPuck J Peltenburg, Dania Kallas, Johan M Bos, et al.
Circulation|July 25, 2024
Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS StudyRachel Lampert, Sharlene Day, Barbara Ainsworth, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
European Heart Journal|July 31, 2018
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroupsAlban-Elouen Baruteau, Florence Kyndt, Elijah R Behr, et al.
Nature Genetics|July 23, 2013
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathConnie R Bezzina, Julien Barc, Yuka Mizusawa, et al.
Circulation|November 15, 2021
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN TrialReinoud E Knops, Willeke van der Stuijt, Peter Paul H M Delnoy, et al.
Circulation. Cardiovascular Quality and Outcomes|November 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN TrialReinoud E Knops, Jolien A de Veld, Abdul Ghani, et al.
Cardiovascular Research|December 5, 2021
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis, Colin Baigent, Stephan Windecker, et al.
Pageof 39